NL
DE
27 August 2018
Editorial article: link.
The article provides evidence that the anti-inflammatory ubiquitin editing enzyme TNFα induced protein 3 (TNFAIP3), also known as A20, acts as a master switch for the expression of IL-17A in human CD4+ T cells derived from Inflammatory Bowel disease (IBD) patients. Due its relevance in the field a JACI editorial article was also published highlighting Urbano and Koenen’s findings. ArticleTNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.
Paulo Urbano and Hans Koenen are member of the theme Inflammatory diseases.
Paulo Urbano and Hans Koenen, theme Inflammatory diseases, recently published an article in the Journal of Allergy and Clinical Immunology (JACI).
Editorial article: link.
The article provides evidence that the anti-inflammatory ubiquitin editing enzyme TNFα induced protein 3 (TNFAIP3), also known as A20, acts as a master switch for the expression of IL-17A in human CD4+ T cells derived from Inflammatory Bowel disease (IBD) patients. Due its relevance in the field a JACI editorial article was also published highlighting Urbano and Koenen’s findings. ArticleTNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.
Paulo Urbano and Hans Koenen are member of the theme Inflammatory diseases.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Dutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs
14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read more
Joyce Aarts and colleagues published in Scientific Reports about the role of TGF-β1 in (experimental) arthritis
30 March 2022 Joyce Aarts, theme Inflammatory diseases, and her colleagues published in Scientific Reports, that local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis. read more
New EU Research project ImmUniverse
27 February 2020 In this project (31 mEURO), RIMLS and RIHS researchers collaborate with 25 European partners on dissecting common disease mechanisms of Ulcerative Colitis and Atopic Dermatitis. read more
Researchers investigate how stem cells affect the immune system
18 February 2020 RIMLS researchers Irma Joosten and Renate van der Molen, participating in an European study into the treatment of brain damage in premature babies. Is it possible to limit or even partly repair the damage with stem cells? They focus primarily on the effect of those stem cells on the immune system. read more
It is raining Horizon 2020 grants for RIMLS researchers
15 August 2019 Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available and running from 2014 to 2020. This summer, no less than 8 proposals for the Radboudumc have been accepted, 4 of them even as a coordinator. read more
